The Food and Drug Administration approved a new chemotherapy drug Thursday for use in patients with cancer of the blood, chronic lymphocytic leukemia (CLL).
Bendamustine hydrochloride, brand name Treanda, attacks and damages cancer cell DNA that leads to death of these cells and also attacks cancer cells when they try to divide
